Cancer-associated retinopathy

Arch Ophthalmol. 1999 Dec;117(12):1641-5. doi: 10.1001/archopht.117.12.1641.

Abstract

Patients with systemic cancer may have a variety of ocular complaints. Most commonly these are metastases or adverse effects of therapy. Paraneoplastic syndromes, like cancer-associated retinopathy, rarely cause ophthalmic symptoms. We describe a patient with a malignant mixed mullerian tumor and cancer-associated retinopathy who had circulating serum antibodies to recoverin and cells positive for recoverin in the tumor. We discuss the typical clinical symptoms as well as the pathophysiology of this uncommon disorder.

Publication types

  • Case Reports

MeSH terms

  • Antigens, Neoplasm / blood
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Biomarkers, Tumor / blood
  • Calcium-Binding Proteins / blood
  • Electroretinography
  • Eye Proteins*
  • Fatal Outcome
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Fundus Oculi
  • Hippocalcin
  • Humans
  • Lipoproteins*
  • Middle Aged
  • Mixed Tumor, Mullerian / immunology
  • Mixed Tumor, Mullerian / pathology*
  • Mixed Tumor, Mullerian / radiotherapy
  • Nerve Tissue Proteins*
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / immunology
  • Paraneoplastic Syndromes / pathology*
  • Prednisone / therapeutic use
  • Recoverin
  • Retinal Diseases / drug therapy
  • Retinal Diseases / immunology
  • Retinal Diseases / pathology*
  • Uterine Neoplasms / immunology
  • Uterine Neoplasms / pathology*
  • Uterine Neoplasms / radiotherapy
  • Visual Acuity
  • Visual Fields

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Calcium-Binding Proteins
  • Eye Proteins
  • Lipoproteins
  • Nerve Tissue Proteins
  • RCVRN protein, human
  • Recoverin
  • Hippocalcin
  • Prednisone